Akses terbuka Jurnal SINTA 1
SARS-CoV-2 Neutralization Assay System using Pseudo-lentivirus
The Indonesian Biomedical Journal · Vol. 15 No. 2 (2023) · hlm. 179–186
- ISSN
- 2085-3297, 2355-9179
- Terbit
- 2023-04-18
- Penerbit
- Secretariat of The Indonesian Biomedical Journal
- Bahasa
- en
Abstrak
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects humans' lower respiratory tracts and causes coronavirus disease-2019 (COVID-19). Neutralizing antibodies is one of the adaptive immune system responses that can reduce SARS-CoV-2 infection. This study aimed to develop a SARS-CoV-2 neutralization assay system using pseudo-lentivirus.METHODS: The plasmid used for pseudo-lentivirus production was characterized using restriction analysis. The gene encoding for SARS-CoV-2 spike protein was confirmed using sequencing. The transfection pseudo-lentivirus optimal condition was determined by choosing the transfection reagents and adding centrifugation step. Optimal pseudo-lentivirus infection was analysed using fluorescent assay and luciferase assay. The optimal condition of pseudo-lentivirus infection was determined by the target cell type and the number of pseudo-lentiviruses used for neutralization test. SARS-CoV-2 pseudo-lentivirus was used to detect neutralizing antibodies from serum samples.RESULTS: The plasmid used for pseudo-lentivirus production was characterized and confirmed to have no mutations. Lipofectamine 2000 reagent generated pseudo-lentivirus with a higher ability to infect target cells, as indicated by a percentage green fluorescent protein (GFP) of 12.68%. Pseudo-lentivirus centrifuged obtained more stable results in luciferase expression. Optimal pseudo-lentivirus infection conditions were obtained using puromycin-selected HEK 293T-ACE2 cells as target cells. The number of pseudo-lentiviruses used in the neutralization assay system was multiplicity of infection (MOI) 0.075. Serum A samples with a 1:10 dilution had the highest neutralizing antibody activity.CONCLUSION: This study shows that SARS-CoV-2 neutralization assay system using pseudo-lentivirus successfully detected neutralizing antibodies in human serum, which were indicated by a decrease in the percentage of pseudo-lentivirus infections.KEYWORDS: COVID-19, neutralizing antibody, neutralization assay, pseudo-lentivirus, SARS-COV-2
Kata kunci
Jaringan kolaborasi para penulis
40 penulis · 219 tautan kepenulisan bersama · 103 lintas organisasi · menampilkan 40 yang paling banyak terhubung
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Bandung Institute of Technology
- National Research and Innovation Agency
- Center for Infectious Disease Education and Research, The University of Osaka
- Indonesian Institute of Sciences
- Atma Jaya Catholic University of Indonesia
- PT Bio Farma (Indonesia)
- Universitas Gadjah Mada
- Afiliasi tidak diketahui
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| DEBBIE SOEFIE RETNONINGRUM | Bandung Institute of Technology | 6 |
| Catur Riani | Bandung Institute of Technology | 4 |
| Anindyajati | Afiliasi tidak diketahui | 3 |
| Ernawati Arifin Giri-Rachman | Bandung Institute of Technology | 3 |
| Salma Aulia Afifah | Bandung Institute of Technology | 3 |
| Raymond R. Tjandrawinata | Atma Jaya Catholic University of Indonesia | 2 |
| Hariyatun Hariyatun | Indonesian Institute of Sciences | 2 |
| Yana Rubiyana | National Research and Innovation Agency | 2 |
| Popi Hadi Wisnuwardhani | National Research and Innovation Agency | 2 |
| Ratih Asmana Ningrum | National Research and Innovation Agency | 2 |
| Fitri Aulia Permatasari | Bandung Institute of Technology | 2 |
| Ferry Iskandar | Bandung Institute of Technology | 2 |
| Dian Fitria Agustiyanti | National Research and Innovation Agency | 2 |
| Marissa Angelina | National Research and Innovation Agency | 2 |
| Andri Wardiana | National Research and Innovation Agency | 2 |
| Azzania Fibriani | Bandung Institute of Technology | 2 |
| Patricia Gita Naully | Bandung Institute of Technology | 2 |
| Neni Nurainy | PT Bio Farma (Indonesia) | 2 |
| Elvi Restiawaty | Bandung Institute of Technology | 2 |
| Wardono Niloperbowo | Bandung Institute of Technology | 2 |
| Rukman Hertadi | Bandung Institute of Technology | 2 |
| Novia Syari Intan | Bandung Institute of Technology | 2 |
| Putri Ayu Fajar | Bandung Institute of Technology | 2 |
| Gladys Emmanuella Putri Wojciechowska | Bandung Institute of Technology | 2 |
| Armini Syamsidi | Bandung Institute of Technology | 1 |
| Anindyajati Anindyajati | Universitas Gadjah Mada | 1 |
| Desriani Desriani | Indonesian Institute of Sciences | 1 |
| Audrey Angelina Putri Taharuddin | Bandung Institute of Technology | 1 |
| Nicholas Yamahoki | Bandung Institute of Technology | 1 |
| Rebecca Stephanie | Bandung Institute of Technology | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.